Aiforia Technologies (OHEL:AIFORIA) ROCE % : -50.87% (As of Dec. 2023)

View and export this data going back to 2021. Start your Free Trial

What is Aiforia Technologies ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Aiforia Technologies's annualized ROCE % for the quarter that ended in Dec. 2023 was -50.87%.

Aiforia Technologies ROCE % Historical Data

The historical data trend for Aiforia Technologies's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Aiforia Technologies ROCE % Chart

Aiforia Technologies Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

ROCE %

Get a 7-Day Free Trial

-81.03

-82.82

-20.70

-32.93

-45.18

Aiforia Technologies Semi-Annual Data
	Dec18	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
ROCE %	Get a 7-Day Free Trial					-20.05	-22.36	-43.48	-41.35	-50.87

Aiforia Technologies ROCE % Calculation

Aiforia Technologies's annualized ROCE % for the fiscal year that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	-12.737	/	( ( (36.478 - 4.167)	+	(28.191 - 4.115) )	/ 2 )
	=	-12.737	/	( (32.311	+	24.076)	/ 2 )
	=	-12.737	/	28.1935
	=	-45.18 %

Aiforia Technologies's ROCE % of for the quarter that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Dec. 2023 )		(Q: Jun. 2023 )		(Q: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Dec. 2023 )		(Q: Jun. 2023 )		(Q: Dec. 2023 )
	=	-13.112	/	( ( (30.995 - 3.515)	+	(28.191 - 4.115) )	/ 2 )
	=	-13.112	/	( ( 27.48	+	24.076 )	/ 2 )
	=	-13.112	/	25.778
	=	-50.87 %

(1) Note: The EBIT data used here is two times the semi-annual (Dec. 2023) EBIT data.

Aiforia Technologies (OHEL:AIFORIA) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Aiforia Technologies ROCE % Related Terms

Thank you for viewing the detailed overview of Aiforia Technologies's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Aiforia Technologies (OHEL:AIFORIA) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Aiforia Technologies PLC (OHEL:AIFORIA) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

L6J:Germany

Address

Pursimiehenkatu 29-31 D, Helsinki, FIN, FI-00150

Website

https://www.aiforia.com

Aiforia Technologies PLC equips pathologists and scientists in preclinical and clinical labs with powerful deep learning artificial intelligence software for translating images into discoveries, decisions, and diagnoses. The cloud based Aiforia products and services aim to escalate the efficiency and precision of medical image analysis beyond current capabilities, across a variety of fields from oncology to neuroscience and more.

Aiforia Technologies (OHEL:AIFORIA) Headlines

No Headlines